Fugro on the growth express

22/03/24 -"An exceptional Q4 showcasing a 28% sequential increase in the top line, following an impressive 27% surge in the 3Q23, has boosted our confidence in Fugro's ability to achieve its revenue target of ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

22/03/24

Download

You may also be interested by these reports :

18/09/26

Valuation Wise

Canada’s possible elevation to the EU’s first “Associate Member” opens a fresh chapter in transatlantic economics — this time between consenting ...

18/09/26

Aker BP

We raise our 2026 reference EPS to USD 4.46 from USD 3.29, and our 2027 estimate to USD 3.77 from USD 3.10. The main driver is the price deck: we ...

17/09/26

Valuation Wise

Both Oils and Semiconductors are the best performers ytd (+50% and +60% respectively), and share having kick-started a new bout of inflation, planet ...

15/09/26

OILS

Oil Supply Disaster

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue